Skip to main
TEM

TEM Stock Forecast & Price Target

TEM Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 46%
Buy 23%
Hold 23%
Sell 8%
Strong Sell 0%

Bulls say

Tempus AI is a rapidly growing biotechnology company, with strong partnerships and collaborations in place to drive revenue growth. While the recent sale of convertible senior notes may be a cause for concern, the company has a large cash position and is well-positioned to expand into new diseases and continue to go public. Overall, the company has a positive outlook for future growth and is a highly rated Buy by analysts.

Bears say

Tempus AI is facing several fundamental challenges that may hinder its growth and profitability. These include potential risks such as lower-than-projected sales growth, inability to develop and secure regulatory approval of new products, and difficulties in acquiring and maintaining partnerships with biopharmaceutical companies. These challenges could result in weaker than expected revenue growth and margin expansion, increase the company's cash burn, and require additional capital raising. Additionally, competition in the decentralized market and the impact of new legislation on laboratory developed tests may impact the company's competitiveness and profitability. Overall, these risks present a negative outlook for Tempus AI's stock.

TEM has been analyzed by 13 analysts, with a consensus rating of Buy. 46% of analysts recommend a Strong Buy, 23% recommend Buy, 23% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tempus AI Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tempus AI Inc (TEM) Forecast

Analysts have given TEM a Buy based on their latest research and market trends.

According to 13 analysts, TEM has a Buy consensus rating as of May 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $69.31, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $69.31, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tempus AI Inc (TEM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.